All Orthomyxoviridae Infections Articles
- High-dose quadrivalent influenza vaccine shows non-inferior immunogenicity in Chinese children aged 6 to 35 months
- mRNA-1010 shows superior efficacy against influenza in older adults
- Coadministration of RSV mRNA vaccine and high-dose flu vaccine noninferior for flu but not for RSV in older adults
- Survey finds physicians show stronger intergroup bias than public on vaccines
- Systematic review synthesizes Rhaponticum species chemistry, traditional uses, and research gaps across multiple conditions
- Narrative review outlines VLP engineering strategies for broadly protective vaccines against multiple viral pathogens
- EBOV-specific gene signature identified in nonhuman primates and human cohorts with Ebola infection
- Review of intranasal influenza vaccines compared to intramuscular seasonal vaccines
- Methodological review assesses phenotypes for classifying respiratory viruses in English health data
- Observational study finds 2024-2025 flu vaccine associated with reduced hospitalization and severe outcomes
- Quadrivalent influenza vaccine shows immunogenicity and safety in Indian population aged 6 months and older
- Surveillance reports low influenza activity in US during summer 2019
- Survey measures influenza vaccination coverage among U.S. adults aged 18 and older
- Influenza and pneumonia death rates examined in US adults aged 65 and older
- VHA report describes in-hospital death rates for COVID-19 versus influenza patients
- Report describes COVID-19 and influenza diagnoses as percentage of US emergency department visits
- Report describes influenza and respiratory virus circulation in the US during the COVID-19 pandemic
- Interim report on 2021-2022 seasonal influenza vaccine effectiveness in the United States
- Influenza activity and vaccine composition for the 2022-23 Northern Hemisphere season in the US
- Observational study tracks influenza and COVID-19 vaccination coverage in US health care personnel
- US adult vaccination coverage for influenza, COVID-19, and RSV reported in observational data
- Report examines vaccination coverage for influenza, RSV, and COVID-19 in US nursing home residents
- Analysis examines influenza hospitalization risk and vaccination coverage by race and ethnicity
- Interim estimates reported for 2024-2025 seasonal influenza vaccine effectiveness in US patients
- CDC reports 2023-24 seasonal influenza vaccine effectiveness estimates for different US age groups
- RSV disease severity compared to COVID-19 and influenza in hospitalized older adults
- Interim Report Estimates Influenza Vaccine Effectiveness in California
- Influenza and COVID-19 vaccination coverage among US hospital and nursing home personnel
- Interim data show 2019-20 flu vaccine reduced doctor visit risk by 45% overall, 55% in children
- Coinfection with SARS-CoV-2 and influenza studied in hospitalized or deceased pediatric patients
- Tennessee children show higher influenza hospitalization and illness rates in 2022-23 season
- Surveillance report tracks influenza-associated hospitalizations in US children and adults
- Surveillance report describes influenza-associated pediatric deaths in 2024-25 season
- Influenza and pertussis cause substantial disease burden in pregnant women and unvaccinated infants
- Influenza and Tdap vaccination coverage among pregnant women in the United States
- Report examines influenza, Tdap, and COVID-19 vaccination coverage and hesitancy in pregnant women
- CDC Advisory Committee Issues Influenza Vaccination Recommendations for 2020-21 Season
- Interim Estimates Reported for 2025-26 Seasonal Influenza Vaccine Effectiveness in US Population
- Interim 2025-26 influenza vaccine effectiveness estimates reported for California residents
- Influenza and COVID-19 vaccination coverage among US health care providers reported for 2024-25 season
- CDC surveillance report tracks influenza-associated hospitalizations in the United States
- ACIP Recommends Routine Annual Influenza Vaccination for All Persons Aged 6 Months and Older
- ACIP Issues Recommendations for Seasonal Influenza Vaccine Use in 2022-23
- Symptom clusters from participatory surveillance data align with specific respiratory pathogens in Dutch and Italian cohorts
- ACIP Issues Recommendations for Seasonal Influenza Prevention and Control with Vaccines
- CDC Issues Recommendations for Seasonal Influenza Prevention and Control with Vaccines
- Reference-free computational method identifies spike-specific BCR sequences with over 90% purity in mRNA vaccinees
- Phase 2 Trial Evaluates mRNA Influenza Vaccines' Safety and Immunogenicity in Adults